6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What are the barriers to care experienced by adolescents and adults living with sickle cell disease in the United States?

          Findings

          This survey study conducted by the Sickle Cell Disease Implementation Consortium enrolled 440 adolescents and adults in 7 different states and found that most respondents were pleased with their usual care physicians but had negative experiences in acute care settings. Pain and the frequency of pain episodes were associated with patient-reported self-efficacy, further emphasizing the association of severe pain with poor outcomes in this population.

          Meaning

          A negative perception of care in the emergency department setting may be a barrier for seeking care among adolescents and adults living with sickle cell disease.

          Abstract

          Importance

          Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the United States, and previous studies have shown that individuals with SCD are affected by multiple health disparities, including stigmatization, inequities in funding, and worse health outcomes, which may preclude their ability to access quality health care. This needs assessment was performed as part of the Sickle Cell Disease Implementation Consortium (SCDIC) to assess barriers to care that may be faced by individuals with SCD.

          Objective

          To assess the SCD-related medical care experience of adolescents and adults with SCD.

          Design, Setting, and Participants

          This one-time survey study evaluated pain interference, quality of health care, and self-efficacy of 440 adults and adolescents (aged 15 to 50 years) with SCD of all genotypes and assessed how these variables were associated with their perceptions of outpatient and emergency department (ED) care. The surveys were administered once during office visits by trained study coordinators at 7 of 8 SCDIC sites in 2018.

          Results

          The SCDIC sites did not report the number of individuals approached to participate in this study; thus, a response rate could not be calculated. In addition, respondents were not required to answer every question in the survey; thus, the response rate per question differed for each variable. Of 440 individuals with SCD, participants were primarily female (245 [55.7%]) and African American (428 [97.3%]) individuals, with a mean (SD) age of 27.8 (8.6) years. The majority of participants (306 of 435 [70.3%]) had hemoglobin SS or hemoglobin S β 0-thalassemia. Most respondents (361 of 437 [82.6%]) reported access to nonacute (usual) SCD care, and the majority of respondents (382 of 413 [92.1%]) noted satisfaction with their usual care physician. Of 435 participants, 287 (66.0%) reported requiring an ED visit for acute pain in the previous year. Respondents were less pleased with their ED care than their usual care clinician, with approximately half (146 of 287 [50.9%]) being satisfied with or perceiving having adequate quality care in the ED. Participants also noted that when they experienced severe pain or clinician lack of empathy, this was associated with a negative quality of care. Age group was associated with ED satisfaction, with younger patients (<19 vs 19-30 and 31-50 years) reporting better ED experiences.

          Conclusions and Relevance

          These results suggested that a negative perception of care may be a barrier for patients seeking care. These findings underscore the necessity of implementation studies to improve access to quality care for this population, especially in the acute care setting.

          Abstract

          This survey study evaluates pain interference, quality of health care, and disease-specific self-efficacy to assess perceived barriers for seeking care among adults and adolescents with sickle cell disease..

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The PhenX Toolkit: Get the Most From Your Measures

          The potential for genome-wide association studies to relate phenotypes to specific genetic variation is greatly increased when data can be combined or compared across multiple studies. To facilitate replication and validation across studies, RTI International (Research Triangle Park, North Carolina) and the National Human Genome Research Institute (Bethesda, Maryland) are collaborating on the consensus measures for Phenotypes and eXposures (PhenX) project. The goal of PhenX is to identify 15 high-priority, well-established, and broadly applicable measures for each of 21 research domains. PhenX measures are selected by working groups of domain experts using a consensus process that includes input from the scientific community. The selected measures are then made freely available to the scientific community via the PhenX Toolkit. Thus, the PhenX Toolkit provides the research community with a core set of high-quality, well-established, low-burden measures intended for use in large-scale genomic studies. PhenX measures will have the most impact when included at the experimental design stage. The PhenX Toolkit also includes links to standards and resources in an effort to facilitate data harmonization to legacy data. Broad acceptance and use of PhenX measures will promote cross-study comparisons to increase statistical power for identifying and replicating variants associated with complex diseases and with gene-gene and gene-environment interactions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Measuring hospital care from the patients' perspective: an overview of the CAHPS Hospital Survey development process.

            To describe the developmental process for the CAHPS Hospital Survey. A pilot was conducted in three states with 19,720 hospital discharges. A rigorous, multi-step process was used to develop the CAHPS Hospital Survey. It included a public call for measures, multiple Federal Register notices soliciting public input, a review of the relevant literature, meetings with hospitals, consumers and survey vendors, cognitive interviews with consumer, a large-scale pilot test in three states and consumer testing and numerous small-scale field tests. The current version of the CAHPS Hospital Survey has survey items in seven domains, two overall ratings of the hospital and five items used for adjusting for the mix of patients across hospitals and for analytical purposes. The CAHPS Hospital Survey is a core set of questions that can be administered as a stand-alone questionnaire or combined with a broader set of hospital specific items.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease.

              Perceived discriminatory experiences in society have been associated with a higher burden of pain among some minority patient populations.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                29 May 2020
                May 2020
                29 May 2020
                : 3
                : 5
                : e206016
                Affiliations
                [1 ]Department of Medicine, University of Alabama, Birmingham, Birmingham
                [2 ]Department of Hematology, Medical College of Georgia, Augusta University, Augusta
                [3 ]Jiann Ping Hsu College of Public Health, Georgia Southern University, Statesboro
                [4 ]School of Public Health, University of Memphis, Memphis, Tennessee
                [5 ]RTI International, Research Triangle Park, North Carolina
                [6 ]Mt Sinai School of Medicine, New York, New York
                [7 ]Duke University School of Nursing, Durham, North Carolina
                [8 ]Department of Pediatrics, Program in Occupational Therapy, Washington University School of Medicine, St Louis, Missouri
                [9 ]Department of Medicine, Program in Occupational Therapy, Washington University School of Medicine, St Louis, Missouri
                [10 ]Department of Surgery, Program in Occupational Therapy, Washington University School of Medicine, St Louis, Missouri
                [11 ]Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri
                [12 ]Department of Hematology, St Jude Children’s Research Hospital, Memphis, Tennessee
                [13 ]University of California, San Francisco, Benioff Children’s Hospital Oakland, Oakland
                Author notes
                Article Information
                Accepted for Publication: March 22, 2020.
                Published: May 29, 2020. doi:10.1001/jamanetworkopen.2020.6016
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Kanter J et al. JAMA Network Open.
                Corresponding Author: Julie Kanter, MD, Department of Medicine, University of Alabama, 1720 Second Avenue South, NP 2510, Birmingham, AL 35294-3300 ( jkanter@ 123456uabmc.edu ).
                Author Contributions: Drs Kanter and Treadwell had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Kanter, Gibson, Lawrence, Smeltzer, Glassberg, Calhoun, Hankins, Treadwell.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Kanter, Gibson, Lawrence, Smeltzer, Pugh, Hankins, Treadwell.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Smeltzer, Pugh, Treadwell.
                Obtained funding: Kanter, Gibson, Glassberg, King, Calhoun, Hankins, Treadwell.
                Administrative, technical, or material support: Kanter, Lawrence, Glassberg.
                Supervision: Glassberg, Calhoun, Treadwell.
                Conflict of Interest Disclosures: Dr Kanter reported receiving grants from the Medical University of South Carolina and from the National Institutes of Health (NIH) during the conduct of the study and receiving personal fees from Novartis and from Bluebird Bio outside the submitted work. Dr Gibson reported receiving grants from the NIH during the conduct of the study. Dr Smeltzer reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the study. Dr Glassberg reported receiving grants from NHLBI during the conduct of the study and grants from Pfizer outside the submitted work. Dr King reported receiving grants from NHLBI during the conduct of the study. Dr Hankins reported receiving grants from NHLBI during the conduct of the study; receiving research support from Novartis, from Global Blood Therapeutics, and from the Links Foundation; and receiving consultant fees from MJH Life Sciences. Dr Treadwell reported receiving grants from NHLBI during the conduct of the study and personal fees from Global Blood Therapeutics and from Pfizer outside the submitted work. No other disclosures were reported.
                Funding/Support: This study was funded by the NHLBI 5U01HL133990-02 grant. The SCD Implementation Consortium has been supported by US Federal Government cooperative agreements HL133948, HL133964, HL133990, HL133994, HL133996, HL133997, HL134004, HL134007, and HL134042 from the NHLBI and the National Institute on Minority Health and Health Disparities (Bethesda, MD).
                Role of the Funder/Sponsor: Program officers from the NHLBI participated in the design of the study. No funder participated in the conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Article
                zoi200282
                10.1001/jamanetworkopen.2020.6016
                7260622
                32469413
                68c54e04-e970-4209-b45f-6e76f4f0872b
                Copyright 2020 Kanter J et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 26 November 2019
                : 22 March 2020
                Categories
                Research
                Original Investigation
                Online Only
                Hematology

                Comments

                Comment on this article